Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Taxane”

435 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 435 results

Large-scale testing (Phase 3)Study completedNCT00103233
What this trial is testing

Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network
Large-scale testing (Phase 3)Looking for participantsNCT05862064
What this trial is testing

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 606
Testing effectiveness (Phase 2)UnknownNCT00066547
What this trial is testing

Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy

Who this might be right for
Breast Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01113463
What this trial is testing

TPI 287 in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 17
Large-scale testing (Phase 3)Ended earlyNCT01303679
What this trial is testing

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

Who this might be right for
First Line Metastatic Breast Cancer
ARCAGY/ GINECO GROUP 117
Not applicableStudy completedNCT02391818
What this trial is testing

The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients

Who this might be right for
Distorted; BalanceQuality of LifeNeuropathy+1 more
OSF Healthcare System 19
Testing effectiveness (Phase 2)Study completedNCT00036751
What this trial is testing

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial CancerStage III Ovarian Epithelial Cancer+1 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00802945
What this trial is testing

Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
TumorBreast Cancer
Nektar Therapeutics 70
Testing effectiveness (Phase 2)Study completedNCT01693549
What this trial is testing

Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

Who this might be right for
Breast Cancer
Hellenic Cooperative Oncology Group 84
Early research (Phase 1)Ended earlyNCT00933426
What this trial is testing

Lenalidomide and Paclitaxel in Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT01540071
What this trial is testing

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
Io Therapeutics 38
Testing effectiveness (Phase 2)Study completedNCT00325234
What this trial is testing

Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 135
Testing effectiveness (Phase 2)Ended earlyNCT00267007
What this trial is testing

Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Who this might be right for
Peripheral Neuropathy, Chemotherapy-induced
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 32
Testing effectiveness (Phase 2)Study completedNCT03272477
What this trial is testing

Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients

Who this might be right for
Breast Neoplasms
Palleos Healthcare GmbH 257
Large-scale testing (Phase 3)Study completedNCT00112294
What this trial is testing

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Eli Lilly and Company 755
Not applicableStudy completedNCT00263861
What this trial is testing

Nerve Function in Older Diabetic Patients Who Are Undergoing Chemotherapy for Metastatic Solid Tumors

Who this might be right for
NeurotoxicityUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 14
Not applicableEnded earlyNCT04932031
What this trial is testing

Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy

Who this might be right for
Breast CancerChemotherapy-induced Peripheral NeuropathyAging
Sapere Bio 123
Not applicableStudy completedNCT03872141
What this trial is testing

Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients

Who this might be right for
Breast CancerChemotherapy Induced Peripheral NeuropathyPaclitaxel Induced Neuropathy
Yale University 13
Post-approval studies (Phase 4)UnknownNCT01049295
What this trial is testing

Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer

Who this might be right for
Breast Cancer
Tehran University of Medical Sciences 52
Testing effectiveness (Phase 2)Study completedNCT00063102
What this trial is testing

ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

Who this might be right for
Breast Cancer
Abbott 40
Load More Results